Has John Hinson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,326 in general payments to John Hinson, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Hinson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Hinson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Hinson, MD

Cardiovascular Disease · Farmington, CTNPI 1609071133

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,455 of the $19,326 with a category attached, or 80.0%. Alnylam Pharmaceuticals Inc. accounts for 83.8% of it on its own, with 4 other manufacturers making up the rest. Among cardiovascular disease clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,326in general payments, 2019–2025

Across 33 payments — averaging $585.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alnylam Pharmaceuticals Inc.$16K
Amgen$3K
Novo Nordisk$222
Abbott$168
Vifor Pharma, Inc.$122

$800in research payments, 2019–2025

Across 1 payment — averaging $800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Biomarin Pharmaceutical Inc.$800

What the payments were for

Consulting fees$15,45580%
Travel & lodging$2,61314%
Food & beverage$1,1616%
Education$971%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alnylam Pharmaceuticals Inc.	21	$16,203
Amgen	6	$2,612
Novo Nordisk	4	$222
Abbott	1	$168
Vifor Pharma, Inc.	1	$122

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,326 in reported general payments places this provider in the 90th percentile of 415 cardiovascular disease providers in Connecticut.

See all cardiovascular disease providers in Connecticut →

Medicare billing

Part B allowed, 2024

$3,937

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Farmington

Shubhi PandeyFarmington$29K
Nihar DesaiNew Haven$1.4M
Brett NowlanBloomfield$798K
Jeffery TestaniNew Haven$546K
Carlos Mena-HurtadoNew Haven$460K
Stephanie SaucierHartford$243K
John ForrestNew Haven$164K
Henry WardNew Haven$152K
Ricardo CordidoHamden$135K
Antonio FernandezHartford$113K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →